While B-type natriuretic peptide (BNP) levels remain high in patients with end-stage heart failure with cardiogenic shock, these levels lose their prognostic value in patients using ventricular assist ...

Addition of soluble urokinase-type plasminogen activator receptor levels to models including B-type natriuretic peptide may improve their prognostic value for patients with HF, researchers reported.

Background: During persistent pulmonary hypertension (PPHN) the pulmonary vascular resistance remains elevated in the neonatal period. Treatment is directed towards decreasing the pulmonary vascular ...

BNP levels are sensitive to such other biological factors as age, gender, sex, weight, and renal function. BNP levels may be elevated in cases of acute MI, pulmonary embolism, and chronic obstructive ...

Brain natriuretic peptide (BNP), a substance secreted by the heart that is associated with congestive heart failure and renal failure, does not predict reduction in systolic blood pressure (BP) in ...

Among patients at risk of heart failure, collaborative care based on screening for certain levels of brain-type natriuretic peptide reduced the combined rates of left ventricular systolic dysfunction, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In patients hospitalized for COVID-19, those with ...

Luís Beck-da-Silva, MD; Adolfo de Bold, PhD, FRSC; Ross A. Davies, MD, FRCPC; Benjamin J.W. Chow, MD, FRCPC; Terrence D. Ruddy, MD, FRCPC; Margaret Fraser, RN ...

Diastolic heart failure is common in the elderly, particularly women. Previous studies on the value of brain natriuretic peptide in diastolic dysfunction have been largely limited to male subjects.

Results reveal that suPAR levels were 17% higher in patients with heart failure than those without across the different subgroups, including patients with ischemic or non-ischemic cardiomyopathy.